» Articles » PMID: 2357866

Differences in Stereoselective Disposition of Propranolol Do Not Explain Sensitivity Differences Between White and Chinese Subjects: Correlation Between the Clearance of (-)- and (+)-propranolol

Overview
Publisher Wiley
Specialty Pharmacology
Date 1990 Jun 1
PMID 2357866
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously demonstrated that Chinese subjects are more sensitive than white subjects to beta-blockade produced by propranolol. To determine if this difference was because a greater proportion of the total propranolol was the more active (-)-isomer of propranolol in the Chinese subjects than in the white subjects, the relative pharmacokinetics of (+)- and (-)-isomers of propranolol after administration of a single, 80 mg oral dose of racemic propranolol was studied in 10 Chinese male and in 9 white male healthy subjects. The plasma concentrations of both (+)- and (-)-propranolol were lower in Chinese than in white subjects, resulting in significantly lower peak plasma concentrations and areas under the concentration-time curve (AUC) in Chinese subjects, the half-life of elimination did not differ significantly between Chinese and white subjects or between the two isomers. The concentrations of the active (-)-propranolol were higher in both groups of subjects because of the lower clearance of the (-)-propranolol compared with the (+)-propranolol. An excellent correlation between the clearance of (+)- and (-)-propranolol was seen in the same individual. The ratio of AUC of (-)- and (+)-propranolol did not differ between Chinese subjects (0.64 +/- 0.03) and white subjects (0.71 +/- 0.09). The data suggest that the proportion of the two isomers found in Chinese and white subjects did not differ, and therefore differences in stereoselective disposition of propranolol cannot explain the increased sensitivity seen in Chinese individuals.

Citing Articles

Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.

Yu G, Zhou H, Zheng Q, Li G Eur J Clin Pharmacol. 2018; 75(4):543-551.

PMID: 30569284 DOI: 10.1007/s00228-018-02610-z.


Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.

Lu S, Nand R, Yang J, Chen G, Gross A Eur J Clin Pharmacol. 2017; 74(3):285-296.

PMID: 29181698 DOI: 10.1007/s00228-017-2375-3.


Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Tfelt-Hansen P, Agesen F, Pavbro A, Tfelt-Hansen J CNS Drugs. 2017; 31(5):389-403.

PMID: 28405886 DOI: 10.1007/s40263-017-0430-3.


Stereoselective steady state disposition and action of propafenone in Chinese subjects.

Li G, Gong P, Qiu J, Zeng F, Klotz U Br J Clin Pharmacol. 1998; 46(5):441-5.

PMID: 9833596 PMC: 1873699. DOI: 10.1046/j.1365-2125.1998.00806.x.


Ethnic differences in drug disposition and responsiveness.

Wood A, Zhou H Clin Pharmacokinet. 1991; 20(5):350-73.

PMID: 1879095 DOI: 10.2165/00003088-199120050-00002.